BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7508968)

  • 1. Inhibition of nitric oxide synthase in experimental gram-negative sepsis.
    Evans T; Carpenter A; Silva A; Cohen J
    J Infect Dis; 1994 Feb; 169(2):343-9. PubMed ID: 7508968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
    Klemm P; Thiemermann C; Winklmaier G; Martorana PA; Henning R
    Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is endotoxin-induced hypotension related to nitric oxide formation?
    Preiser JC; Zhang H; Wachel D; Boeynaems JM; Buurman W; Vincent JL
    Eur Surg Res; 1994; 26(1):10-8. PubMed ID: 7511103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhibition of nitric oxide synthesis on TNF alpha serum levels in E. coli endotoxemic rats.
    Boczkowski J; Philip I; Tedgui A; Bernard C; Merval R; Desmonts JM; Aubier M
    Life Sci; 1995; 57(13):PL147-52. PubMed ID: 7545771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia.
    Harbrecht BG; Di Silvio M; Demetris AJ; Simmons RL; Billiar TR
    Hepatology; 1994 Oct; 20(4 Pt 1):1055-60. PubMed ID: 7927208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines.
    Freeman BD; Zeni F; Banks SM; Eichacker PQ; Bacher JD; Garvey EP; Tuttle JV; Jurgensen CH; Natanson C; Danner RL
    Crit Care Med; 1998 May; 26(5):877-86. PubMed ID: 9590318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone.
    Teale DM; Atkinson AM
    J Antimicrob Chemother; 1992 Dec; 30(6):839-42. PubMed ID: 1283860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Petros A; Bennett D; Vallance P
    Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cyclic guanosine monophosphate production during Escherichia coli septic shock.
    Rosenberg RB; Broner CW; O'Dorisio MS
    Biochem Med Metab Biol; 1994 Apr; 51(2):149-55. PubMed ID: 8043298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW; McCreedy SA
    Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
    Schilling J; Cakmakci M; Bättig U; Geroulanos S
    Intensive Care Med; 1993; 19(4):227-31. PubMed ID: 7690053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis.
    Strand OA; Leone AM; Giercksky KE; Skovlund E; Kirkebøen KA
    Crit Care Med; 1998 Sep; 26(9):1490-9. PubMed ID: 9751584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary hydraulic conductivity is decreased by nitric oxide synthase inhibition.
    Rumbaut RE; McKay MK; Huxley VH
    Am J Physiol; 1995 May; 268(5 Pt 2):H1856-61. PubMed ID: 7539589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse.
    Rees DD; Monkhouse JE; Cambridge D; Moncada S
    Br J Pharmacol; 1998 Jun; 124(3):540-6. PubMed ID: 9647479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
    Nava E; Palmer RM; Moncada S
    Lancet; 1991 Dec 21-28; 338(8782-8783):1555-7. PubMed ID: 1683974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ; Fickling SA; Whitley GS; Vallance P
    Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats.
    Hollenberg SM; Cunnion RE; Zimmerberg J
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H660-3. PubMed ID: 7680541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
    Laszlo F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.